Compounds > gliclazide

gliclazide and Clinically Isolated CNS Demyelinating Syndrome

gliclazide has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bai, X; Cheng, Y; Ding, H; Fan, S; Jiang, Y; Li, J; Tian, H; Zhang, Y1

Other Studies

1 other study(ies) available for gliclazide and Clinically Isolated CNS Demyelinating Syndrome

ArticleYear
18β-Glycyrrhetinic acid alleviates demyelination by modulating the microglial M1/M2 phenotype in a mouse model of cuprizone-induced demyelination.
    Neuroscience letters, 2021, 06-11, Volume: 755

    Topics: Animals; Cuprizone; Demyelinating Diseases; Glycyrrhetinic Acid; Locomotion; Male; Mice; Mice, Inbred C57BL; Microglia; Myelin Sheath; Phenotype

2021